Full Year 2024 Results Key Financial Results Revenue: US$56.3b (up 3.7% from FY 2023). Net ...
This month’s focus on pharmaphorum is clinical trials, so who better to share their view on global clinical trials than Zheng Su, Editor-in-Chief of the Contemporary Clinical Trials journal.
Micrograph of a diffuse large B cell lymphoma, AbbVie and partner Genmab have FDA ... As a rough comparison, in a similar trial population glofitamab had an overall response rate of 52%, with ...
Research reports from Morningstar & Argus help you make better investment decisions. Leverage these to understand future stock performance and identify high performing investment ideas. You can ...